Cargando…

Association between plasma exosome neurogranin and brain structure in patients with Alzheimer’s disease: a protocol study

INTRODUCTION: Neurogranin is known to be significantly elevated in patients with Alzheimer’s disease (AD) and may be an effective clinical predictor of cognitive decline and neurodegeneration. Amnestic mild cognitive impairment (aMCI) is an intermediate disease state between normal cognitive ageing...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, MengFei, Sun, Li, Cao, Wenhui, Yin, Changhao, Sun, Wenqiang, Liu, Ping, Tan, Lin, Xu, Zheng, Zhao, Weina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430441/ https://www.ncbi.nlm.nih.gov/pubmed/32801201 http://dx.doi.org/10.1136/bmjopen-2020-036990

Ejemplares similares

MRI-based comparative study of different mild cognitive impairment subtypes: protocol for an observational case–control study
por: Yu, Yang, et al.
Publicado: (2017)

Association of cerebrospinal fluid neurogranin levels with cognition and neurodegeneration in Alzheimer’s disease
por: Xue, Mei, et al.
Publicado: (2020)

Neurogranin as a cognitive biomarker in cerebrospinal fluid and blood exosomes for Alzheimer’s disease and mild cognitive impairment
por: Liu, Weilin, et al.
Publicado: (2020)

Association of neurogranin gene expression with Alzheimer's disease pathology in the perirhinal cortex
por: Sun, Xiaoyan, et al.
Publicado: (2021)

The role of neurogranin in exercise-induced adaptation to brain
por: Radák, Zsolt
Publicado: (2023)

Exosomal miRNA-223-3p as potential biomarkers in patients with cerebral small vessel disease cognitive impairment
por: Zhao, Weina, et al.
Publicado: (2021)

Cerebrospinal fluid neurogranin and YKL‐40 as biomarkers of Alzheimer's disease
por: Janelidze, Shorena, et al.
Publicado: (2015)

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
por: Mattsson, Niklas, et al.
Publicado: (2016)

CSF neurogranin or tau distinguish typical and atypical Alzheimer disease
por: Wellington, Henrietta, et al.
Publicado: (2018)

Neurogranin as a Reliable Biomarker for Synaptic Dysfunction in Alzheimer’s Disease
por: Agnello, Luisa, et al.
Publicado: (2021)

Neurogranin Regulates Metaplasticity
por: Zhong, Ling, et al.
Publicado: (2020)

CSF profiling of the human brain enriched proteome reveals associations of neuromodulin and neurogranin to Alzheimer's disease
por: Remnestål, Julia, et al.
Publicado: (2016)

Neurogranin-like immunoreactivity in the zebrafish brain during development
por: Alba-González, Anabel, et al.
Publicado: (2022)

Neurogranin and Neuronal Pentraxin Receptor as Synaptic Dysfunction Biomarkers in Alzheimer’s Disease
por: Dulewicz, Maciej, et al.
Publicado: (2021)

Characterization of transcriptional regulation of neurogranin by nitric oxide and the role of neurogranin in SNP-induced cell death: implication of neurogranin in an increased neuronal susceptibility to oxidative stress
por: Gui, Jingang, et al.
Publicado: (2007)

The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer’s disease
por: Kvartsberg, Hlin, et al.
Publicado: (2018)

Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic stroke
por: De Vos, Ann, et al.
Publicado: (2017)

Trajectories of the Hippocampal Subfields Atrophy in the Alzheimer’s Disease: A Structural Imaging Study
por: Zhao, Weina, et al.
Publicado: (2019)

Brain imaging of mild cognitive impairment and Alzheimer's disease
por: Yin, Changhao, et al.
Publicado: (2013)

Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer’s disease
por: Hellwig, Konstantin, et al.
Publicado: (2015)

Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer’s disease patients and healthy controls
por: Kvartsberg, Hlin, et al.
Publicado: (2015)

Molecular forms of neurogranin in cerebrospinal fluid
por: Nazir, Faisal Hayat, et al.
Publicado: (2020)

Distribution of neurogranin‐like immunoreactivity in the brain and sensory organs of the adult zebrafish
por: Alba‐González, Anabel, et al.
Publicado: (2022)

Alzheimer-associated cerebrospinal fluid fragments of neurogranin are generated by Calpain-1 and prolyl endopeptidase
por: Becker, Bruno, et al.
Publicado: (2018)

Cerebrospinal Fluid YKL-40 and Neurogranin in Familial Alzheimer’s Disease: A Pilot Study
por: Thordardottir, Steinunn, et al.
Publicado: (2020)

MCP-1 levels in astrocyte-derived exosomes are changed in preclinical stage of Alzheimer's disease
por: Wang, Ting, et al.
Publicado: (2023)

Safety and efficacy of plasma transfusion from exercise-trained donors in patients with early Alzheimer’s disease: protocol for the ExPlas study
por: Tari, Atefe R, et al.
Publicado: (2022)

The Cerebrospinal Fluid Neurogranin/BACE1 Ratio is a Potential Correlate of Cognitive Decline in Alzheimer’s Disease
por: De Vos, Ann, et al.
Publicado: (2016)

Neurogranin and VILIP-1 as Molecular Indicators of Neurodegeneration in Alzheimer’s Disease: A Systematic Review and Meta-Analysis
por: Dulewicz, Maciej, et al.
Publicado: (2020)

Full-length and C-terminal neurogranin in Alzheimer’s disease cerebrospinal fluid analyzed by novel ultrasensitive immunoassays
por: Öhrfelt, Annika, et al.
Publicado: (2020)

The Effects of CSF Neurogranin and APOE ε4 on Cognition and Neuropathology in Mild Cognitive Impairment and Alzheimer’s Disease
por: Fan, Yulan, et al.
Publicado: (2021)

Neurogranin regulates CaM dynamics at dendritic spines
por: Petersen, Amber, et al.
Publicado: (2015)

Cerebrospinal fluid neurogranin and TREM2 in Huntington’s disease
por: Byrne, Lauren M., et al.
Publicado: (2018)

Neurogranin: A Potential Biomarker of Neurological and Mental Diseases
por: Xiang, Yang, et al.
Publicado: (2020)

Neurogranin regulates eNOS function and endothelial activation
por: Cheriyan, Vino T., et al.
Publicado: (2020)

Neurogranin and Neurofilament Light Chain as Preclinical Biomarkers in Scrapie
por: Betancor, Marina, et al.
Publicado: (2022)

Plasma p-tau181 Level Predicts Neurodegeneration and Progression to Alzheimer's Dementia: A Longitudinal Study
por: Wang, Yan-Li, et al.
Publicado: (2021)

Soluble Insulin Receptor Levels in Plasma, Exosomes, and Urine and Its Association With HIV-Associated Neurocognitive Disorders
por: Cantres-Rosario, Yisel M., et al.
Publicado: (2022)

Albumin Exchange in Alzheimer's Disease: Might CSF Be an Alternative Route to Plasma?
por: Menendez-Gonzalez, Manuel, et al.
Publicado: (2019)

Increased levels of the synaptic proteins PSD-95, SNAP-25, and neurogranin in the cerebrospinal fluid of patients with Alzheimer’s disease
por: Kivisäkk, Pia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lt8d44cf25uuv7cc097erovii8